Clinical Study
Usefulness of Change in Estimated Glomerular Filtration Rate as a Predicting Factor of Progression of Chronic Kidney Disease
Table 2
Basic characteristics of remission and no-remission groups.
| | | Remission group | No-remission group | P |
| Gender; no. of patients (%) | | | | 0.042
| Female | | 9 (20.9%) | 29 (41.4%) | Male | | 34 (79.1%) | 41 (58.6%) | Age; years | | 65.8 ± 12.8 () | 68.6 ± 11.0 () | 0.221 | Underlying disease; no. of patients (%) | | | | 0.421
| Non-diabetic | | 31 (72.1%) | 44 (62.9%) | Diabetic | | 12 (27.9%) | 26 (37.1%) | CKD stage; no. of patients (%) | | | | 0.194
| III | | 5 (11.6%) | 3 (4.3%) | IV | | 25 (58.1%) | 37 (52.9%) | V | | 13 (30.2%) | 30 (42.9%) | eGFR; mL/min/1.73 m2 | | 20.8 ± 8.6 () | 17.3 ± 6.1 ) | 0.026 | serum creatinine; mg/dL | | 3.0 ± 1.5 () | 3.0 ± 1.0 () | 0.914 | Total protein; g/dL | | 7.2 ± 0.7 () | 7.0 ± 0.7 () | 0.126 | Albumin; g/dL | | 3.9 ± 0.6 () | 3.8 ± 0.5 () | 0.697 | Urea nitrogen; mg/dL | | 38.7 ± 13.1 () | 40.6 ± 11.8 () | 0.433 | Uric acid; mg/dl | | 7.4 ± 2.0 () | 7.0 ± 1.6 () | 0.239 | Calcium; mg/dL | | 9.0 ± 0.9 () | 8.8 ± 0.6 () | 0.181 | Inorganic phosphate; mg/dL | | 3.7 ± 0.8 () | 4.0 ± 0.8 () | 0.201 | Total cholesterol; mg/dL | | 200.5 ± 44.8 () | 196.3 ± 46.3 () | 0.652 | Urinary protein; g/g·Cr | | 2.1 ± 2.9 () | 3.6 ± 3.2 () | 0.036 | Hemoglobin A1c; % | | 6.5 ± 1.8 () | 6.2 ± 1.2 () | 0.400 | Hemoglobin; g/dL | | 11.6 ± 2.0 () | 10.7 ± 1.9 () | 0.013 | Hematocrit; % | | 35.7 ± 5.7 () | 32.9 ± 5.3 () | 0.009 |
|
|
Data are presented in means ± SD, unless stated otherwise. eGFR: estimated glomerular filtration rate.
|